<--- Back to Details
First PageDocument Content
Drugs / Chemistry / Morphinans / Medicare Part D / Over-the-counter drug / Cough medicine / Mucokinetics / Pharmaceuticals policy / Pharmacology / Medicine
Date: 2014-12-10 09:45:58
Drugs
Chemistry
Morphinans
Medicare Part D
Over-the-counter drug
Cough medicine
Mucokinetics
Pharmaceuticals policy
Pharmacology
Medicine

Attachment 3.1-A.1 Page 14h State Plan Under Title XIX of the Social Security Act Medical Assistance Program State: NORTH CAROLINA Medicaid Program: Requirements Relating to Covered Outpatient Drugs for the Categorically

Add to Reading List

Source URL: www.ncdhhs.gov

Download Document from Source Website

File Size: 31,26 KB

Share Document on Facebook

Similar Documents

Announcement of Calendar Year (CYMedicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter and Request for Information

Announcement of Calendar Year (CYMedicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter and Request for Information

DocID: 1xTu9 - View Document

Medicare Part D stand-alone prescription drug plans for 2018 People who get their health benefits from a Medicare supplement policy or a non-managed care Medicare Advantage plan with no drug coverage may enroll in a stan

Medicare Part D stand-alone prescription drug plans for 2018 People who get their health benefits from a Medicare supplement policy or a non-managed care Medicare Advantage plan with no drug coverage may enroll in a stan

DocID: 1tPLN - View Document

Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing (OEI; 07/17)

Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing (OEI; 07/17)

DocID: 1ttzb - View Document

Mirror, Mirror on the Wall: Medicare Part D pays needlessly high brand-name drug prices compared with other OECD countries and with U.S. government programs By Marc-André Gagnon, PhD.

Mirror, Mirror on the Wall: Medicare Part D pays needlessly high brand-name drug prices compared with other OECD countries and with U.S. government programs By Marc-André Gagnon, PhD.

DocID: 1th0B - View Document

Coalition of 26 Groups to Congress: Oppose Medicare Part D Rebate Proposals June 21, 2016 Dear Senators and Representatives: In the final months of the Obama Administration, the White House and Congress will engage in an

Coalition of 26 Groups to Congress: Oppose Medicare Part D Rebate Proposals June 21, 2016 Dear Senators and Representatives: In the final months of the Obama Administration, the White House and Congress will engage in an

DocID: 1sahA - View Document